Filing metadata

Accession number
0001415889-25-008974
Form type
Form 3
Filer
Kalaris Therapeutics, Inc.
CIK
CIK 1754068
Filed
Mar 25, 2025
Reporting period
Mar 18, 2025
Description
Initial ownership

Explore SEC Filings Hub